MYC amplification was a potentially new mechanism of primary ALK-TKI, resistance and proposed as a potential MYC-oriented inhibition strategy to overcome primary resistance of advanced ALK-rearrangement NSCLC (99). This evidence concerns the gene ALK and non-small cell lung carcinoma.